BTK and autoimmune disease: Amelioration of autoimmune pathology by Btk deletion in our studies is consistent with our and others’ prior studies indicating contribution of altered B cell signaling to autoimmunity and support the therapeutic use of Btk inhibitors in autoimmune diseases (41, 42, 79).